Document Type
Article
Publication Date
4-26-2016
Graduation Year
2017
Abstract
The stage has officially been set for one of the largest biotech patent disputes to date. The stakes are high in this clash between scientific powerhouses: a potential Nobel Prize, the patent rights to a breakthrough gene-editing process, and (of course) a lot of money for the research institution involved.
This post was originally published on the Cardozo Arts & Entertainment Law Journal website on April 26, 2016. The original post can be accessed via the Archived Link button above.
Recommended Citation
Thalen, Katie, "The CRISPR-Cas9 Patent Dispute" (2016). AELJ Blog. 112.
https://larc.cardozo.yu.edu/aelj-blog/112
